{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:16:13Z","timestamp":1761516973743,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772852","81972496"],"award-info":[{"award-number":["81772852","81972496"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.eprac.2021.02.008","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T09:48:50Z","timestamp":1613900930000},"page":"912-917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Choosing Optimal Microcarcinoma Patients for Active Surveillance Study (Compass): Effectiveness Evaluation of a Preoperative Clinical Framework"],"prefix":"10.1016","volume":"27","author":[{"given":"Kai","family":"Qian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengmeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixia","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8121-5286","authenticated-orcid":false,"given":"Zhuoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.eprac.2021.02.008_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s00268-015-3392-y","article-title":"Clinical trials of active surveillance of papillary microcarcinoma of the thyroid","volume":"40","author":"Miyauchi","year":"2016","journal-title":"World J Surg"},{"issue":"7","key":"10.1016\/j.eprac.2021.02.008_bib2","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1089\/thy.2018.0711","article-title":"Quality of life in patients with papillary thyroid microcarcinoma managed by active surveillance or lobectomy: a cross-sectional study","volume":"29","author":"Jeon","year":"2019","journal-title":"Thyroid"},{"issue":"10","key":"10.1016\/j.eprac.2021.02.008_bib3","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.4158\/EP171933.OR","article-title":"Nonoperative management of differentiated thyroid cancer in California: a population-level analysis of 29,978 patients","volume":"23","author":"Kuo","year":"2017","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.eprac.2021.02.008_bib4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1089\/thy.2015.0178","article-title":"A\u00a0clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma","volume":"26","author":"Brito","year":"2016","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.eprac.2021.02.008_bib5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1089\/thy.2016.0568","article-title":"Applying criteria of active surveillance to low-risk papillary thyroid cancer over a decade: how many surgeries and complications can be avoided?","volume":"27","author":"Griffin","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2021.02.008_bib6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1055\/a-1015-6684","article-title":"Active surveillance in adults with low-risk papillary thyroid microcarcinomas: a prospective study","volume":"51","author":"Rosario","year":"2019","journal-title":"Horm Metab Res"},{"issue":"1","key":"10.1016\/j.eprac.2021.02.008_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.eprac.2021.02.008_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020298","article-title":"A\u00a0protocol for a Canadian prospective observational study of decision-making on active surveillance or surgery for low-risk papillary thyroid cancer","volume":"8","author":"Sawka","year":"2018","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.eprac.2021.02.008_bib9","doi-asserted-by":"crossref","first-page":"dgz113","DOI":"10.1210\/clinem\/dgz113","article-title":"Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at a single Italian Center","volume":"105","author":"Molinaro","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.eprac.2021.02.008_bib10","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1089\/thy.2019.0159","article-title":"Active surveillance for small papillary thyroid cancer: a systematic review and meta-analysis","volume":"29","author":"Cho","year":"2019","journal-title":"Thyroid"},{"issue":"S2","key":"10.1016\/j.eprac.2021.02.008_bib11","doi-asserted-by":"crossref","DOI":"10.1017\/S0022215116000578","article-title":"Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines","volume":"130","author":"Mitchell","year":"2016","journal-title":"J\u00a0Laryngol Otol"},{"issue":"6","key":"10.1016\/j.eprac.2021.02.008_bib12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1089\/thy.2019.0698","article-title":"Preoperative and postoperative risk stratification of thyroid papillary microcarcinoma: a comparative study between Kuma criteria and 2015 American Thyroid Association Guidelines risk stratification","volume":"30","author":"P\u00e9rez-Soto","year":"2020","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.eprac.2021.02.008_bib13","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1089\/thy.2018.0263","article-title":"Active surveillance of low-risk papillary thyroid microcarcinoma: A multi-center cohort study in Korea","volume":"28","author":"Oh","year":"2018","journal-title":"Thyroid"},{"issue":"11","key":"10.1016\/j.eprac.2021.02.008_bib14","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1089\/thy.2019.0100","article-title":"Computed tomography for detecting cervical lymph node metastasis in patients who have papillary thyroid microcarcinoma with tumor characteristics appropriate for active surveillance","volume":"29","author":"Lee","year":"2019","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.eprac.2021.02.008_bib15","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1089\/thy.2016.0109","article-title":"Challenges of active surveillance protocols for low-risk papillary thyroid microcarcinoma in the United States","volume":"26","author":"Haser","year":"2016","journal-title":"Thyroid"},{"issue":"11","key":"10.1016\/j.eprac.2021.02.008_bib16","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1007\/s00432-019-03021-y","article-title":"Active surveillance of low-risk papillary thyroid carcinoma: a promising strategy requiring additional evidence","volume":"145","author":"Ze","year":"2019","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"6","key":"10.1016\/j.eprac.2021.02.008_bib17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jamaoncol.2019.0054","article-title":"The role of disease label in patient perceptions and treatment decisions in the setting of low-risk malignant neoplasms","volume":"5","author":"Dixon","year":"2019","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.eprac.2021.02.008_bib18","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/s00268-009-0359-x","article-title":"Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes","volume":"34","author":"Sugitani","year":"2010","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.eprac.2021.02.008_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/thy.2013.0367","article-title":"Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation","volume":"24","author":"Ito","year":"2014","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.eprac.2021.02.008_bib20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1210\/jc.2017-01775","article-title":"High serum TSH level is associated with progression of papillary thyroid microcarcinoma during active surveillance","volume":"103","author":"Kim","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2021.02.008_bib21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000503064","article-title":"Active surveillance of papillary thyroid microcarcinoma: where do we stand?","volume":"8","author":"Jeon","year":"2019","journal-title":"Eur Thyroid J"},{"issue":"5","key":"10.1016\/j.eprac.2021.02.008_bib22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/thy.2017.0501","article-title":"Kallikreins stepwise scoring reveals three subtypes of papillary thyroid cancer with prognostic implications","volume":"28","author":"Buj","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2021.02.008_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejca.2019.10.017","article-title":"BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma","volume":"124","author":"Kim","year":"2020","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.eprac.2021.02.008_bib24","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1507\/endocrj.EJ16-0097","article-title":"Pathological characteristics of low-risk papillary thyroid microcarcinoma with progression during active surveillance","volume":"63","author":"Hirokawa","year":"2016","journal-title":"Endocr J"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X21000513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X21000513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:10:11Z","timestamp":1761516611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X21000513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1530891X21000513"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2021.02.008","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Choosing Optimal Microcarcinoma Patients for Active Surveillance Study (Compass): Effectiveness Evaluation of a Preoperative Clinical Framework","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2021.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}